Skip to main content
SpringerLink
Log in
Book cover

Low-Cost Approaches to Promote Physical and Mental Health pp 119–138Cite as

Herbal Medicines in the Treatment of Psychiatric and Neurological Disorders

  • Chapter

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abdullaev, F. I. (2002). Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Experimental Biology and Medicine, 227, 20–25.

    PubMed  Google Scholar 

  • Abe, K., & Saito, H. (2000). Effects of saffron and its constituent crocin on learning behavior and long-term potentiation. Phytotherapy Research, 14, 149–152.

    Article  PubMed  Google Scholar 

  • Akhondzadeh, S., Naghavi, H. R., Vazirian, M., Shayeganpour, A., Rashidi, H., & Khani, M. (2001a). Passionflower in the treatment of generalized anxiety: A double-blind and randomized trial with oxazepam. Journal of Clinical Pharmacy and Therapeutics, 26, 363–367.

    Article  Google Scholar 

  • Akhondzadeh, S., Kashani, L., Mobaseri, M., Hosseini, S. H., Nikzad, S., & Khani, M. (2001b). Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial. Journal of Clinical Pharmacy and Therapeutics, 26, 369–373.

    Article  Google Scholar 

  • Akhondzadeh, S., & Noroozian, M. (2002). Alzheimer’s disease: pathophysiology and Pharmacotherapy. Idrugs, 4, 1167–1172.

    Google Scholar 

  • Akhondzadeh, S., Noroozian, M., Mohammadi, M., & Ohadinia, S. (2003a). Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: a double blind, randomised, placebo controlled trial. Journal of Neurology, Neurosurgery and Psychiatry, 74, 863–866.

    Article  Google Scholar 

  • Akhondzadeh, S., Noroozian, M., Mohammadi, M., & Ohadinia, S. (2003b). Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: a double blind, randomized and placebo-controlled trial. Journal of Clinical Pharmacy and Therapeutics, 28, 53–59.

    Article  Google Scholar 

  • Akhondzadeh, S., Kashani, L., Fotouhi, A., & Jarvandi, S. (2003). Comparison of Lavandula angostofolia Mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized pilot study. Progress in Neuropsychopharmacology and Biological Psychiatry, 27, 123–127.

    Article  Google Scholar 

  • Akhondzadeh, S., Fallah Pour, H., Afkham, K., Jamshidi, A. H., & Khalighi-Cigarodi, F. (2004). Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]. BMC Complementary and Alternative Medicine, 4, 12.

    Article  PubMed  Google Scholar 

  • Akhondzadeh, S., Tamacebi-pour, N., Noorbala, A. A., Amini, H., Fallah Pour, H., Jamshidi, A. H., & Khani, M. (2005a). Crocus sativus L. in the treatment of mild to moderate depression: A double-blind, randomized and placebo controlled trial. Phytotherapy Research, 19, 25–29.

    Article  Google Scholar 

  • Akhondzadeh, S., Mohammadi, M. R., & Momeni F. (2005b). Passiflora incarnata in treatment of attention-deficit hyperactivity disorder in children and adolescents. Therapy, 2, 609–614.

    Article  Google Scholar 

  • Astin, J. A. (1998). Why patients use alternative medicine: results of a national study. Journal of the American Medical Association, 279, 1548–1553.

    Article  PubMed  Google Scholar 

  • Balderer, G., & Borbely, A. A. (1985). Effect of valerian on human sleep. Psychopharmacology, 87, 406–409.

    Article  PubMed  Google Scholar 

  • Becker, B., Bock, B., & Carmona-Barros, R. (2003). St John’s Wort oral spray reduces withdrawal symptoms during quitting smoking. In: Society for Research on Nicotine and Tobacco 9th Annual Meeting, New Orleans, Louisiana.

    Google Scholar 

  • Brue, A. W., & Oakland, T. D. (2002). Alternative treatments for attention deficit hyperactivity disorders: Does evidence support their use. Alternative Therapy Medicine, 8, 68–74.

    Google Scholar 

  • Bullock, R. (2001). Drug treatment in dementia. Current Opinion in Psychiatry, 14, 349–353.

    Article  Google Scholar 

  • Bullock, R. (2002). New drugs for Alzheimer’s disease and other dementias. British Journal of Psychiatry, 180, 135–139.

    Article  PubMed  Google Scholar 

  • Connor, K. M., & Davidson, J. R. (2002). A placebo-controlled study of Kava kava in generalized anxiety disorder. International Clinical Psychopharmacology, 17, 185–188.

    Article  PubMed  Google Scholar 

  • Catania, M. A., Firenzuoli, F., & Crupi, A. (2003). Hypericum perforatum attenuates nicotine withdrawal signs in mice. Psychopharmacology, 169, 186–189.

    Article  PubMed  Google Scholar 

  • Dean, A. J. (2005). Natural and complementary therapies for substance use disorders. Current Opinion in Psychiatry, 18, 271–276.

    Article  PubMed  Google Scholar 

  • Delaveau, P., Guillemain, J., Narcisse, G., & Rousseau, A. (1989). Neurodepressive properties of essential oil of lavender. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, 183, 342–348.

    PubMed  Google Scholar 

  • De Feudis, F. V. (1991). Gingko biloba extract (EGb761): pharmacological activities and clinical applications. Paris: Elsevier.

    Google Scholar 

  • Donath, F., Quispe, S., & Diefenbach, K. (2000). Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry, 33, 47–53.

    Article  PubMed  Google Scholar 

  • Evans, D. A., Funkenstein, H. H., & Albert, M. S. (1989). Prevalence of Alzheimer’s disease in a community population of older persons: higher than previously reported. Journal of the American Medical Association, 262, 2551–2556.

    Article  PubMed  Google Scholar 

  • Francis, P. T., Palmer, A. M., Snape, M., & Wilcock, G. K. (1999). The cholinergic hypothesis of Alzheimer’s disease: a review of progress. Journal of Neurology, Neurosurgery and Psychiatry, 54, 137–147.

    Google Scholar 

  • Gaster, B., & Holroyd, J. (2000). St. John’s wort for depression: A systematic review. Archive of Internal of Medicine, 160, 152–156.

    Article  Google Scholar 

  • Geldmacher, D. S., & Whitehouse, P. J. (1997). Differential diagnosis of Alzheimer’s disease. Neurology, 48(Suppl. 6), S2–S9.

    PubMed  Google Scholar 

  • Gelenberg, A. J. (2000). St. John’s Wort update. Biological Therapies in Psychiatry, 23, 22–24.

    Google Scholar 

  • Hansgen, K. D., Vesper, J., & Ploch, M. (1994). Multicenter double-blind study examining the antidepressant effectiveness of the hypericum extract L160. Journal of Geriatric Psychiatry and Neurology, 7, S15–S18.

    Article  PubMed  Google Scholar 

  • Hosseinzadeh, H., & Younesi, H. (2002). Petal and stigma extracts of Crocus sativus L. have antinociceptive and anti-inflammatory effects in mice. BMC Pharmacology, 2, 7.

    Article  PubMed  Google Scholar 

  • Kanowski, S., & Hoerr, R. (1997). Proof of the efficacy of the gingko biloba special extract egb761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type of multi-infarct dementia. Phytomedicine, 4, 215–222.

    Google Scholar 

  • Kennedy, D. O., Scholey, A. B., Tildesley, N. T. J., Perry, E. K., & Wesnes, K. A. (2002). Modulation of mood and cognitive performance following acte adminstration of Melissa officinalis (lemon balm). Pharmacology and Biochemistry and Behavior, 72, 953–964.

    Article  Google Scholar 

  • Kim, H. L., Streltzer, J., & Goebert, D. (1999). St. John’s wort for depression: A meta-analysis of well-defined clinical trials. Journal of Nervous and Mental Disease, 187, 532–539.

    Article  PubMed  Google Scholar 

  • Kleijnen, J. (1992). Gingko biloba. Lancet, 340, 1136–1139

    Article  PubMed  Google Scholar 

  • Le Bars, P. L., Katz, M. M., Berman, N., Itil, T. M., Freedman, A. M., & Schatzberg, A. F. (1997). A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. Journal of the American Medical Association, 278, 1327–1332.

    Article  PubMed  Google Scholar 

  • Le Bars, P. L., Kieser, M., & Itil, K. Z. (2000). A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia. Dementia, Geriatric and Cognition Disorder, 11, 230–237.

    Article  Google Scholar 

  • Lehmann, E., Kinzler, E., & Friedmann, J. (1996). Efficacy of a special Kava extract (Piper methysticum) in patients with states of anxiety, tension, excitedness of non-mental origin: A double-blind, placebo-controlled study of four weeks treatment. Phytomedicine, 3, 113–119.

    Google Scholar 

  • Lieberman, S. (1998). Nutriceutical review of St. John’s wort (hypericum perforatum) for the treatment of depression. Journal of Women’s Health, 7, 177–182.

    Article  PubMed  Google Scholar 

  • Linde, K., Ramirez, G., & Mulrow, C. D. (1996). St. John’s wort for depression: An overview and meta-analysis of randomised clinical trials. BMJ, 313, 253–258.

    PubMed  Google Scholar 

  • Lindenberg, D., & Pitule-Schodel, H. (1990). Kava in comparison with oxazepam and anxiety disorders: A double- blind study of clinical effectiveness. Fortschr Medicine, 108, 49–54.

    Google Scholar 

  • Livingston, G., & Katona, C. (2000). How useful are cholinesterase inhibitor in the treatment of Alzheimer’s disease? A number needed to treat analysis. International Journal of Geriatric Psychiatry, 15, 203–207.

    Article  PubMed  Google Scholar 

  • Medical Economics. (2000). PDR (Physicians’ Desk Reference) for Herbal Medicines (2nd edn). Montvale, NJ: Medical Economics Company.

    Google Scholar 

  • McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of AD: Report of NINCDS-ADRDA work group under the auspices of department of health and human services task force on AD. Neurology, 34, 939–944.

    PubMed  Google Scholar 

  • Noorbala, A. A., Akhondzadeh, S., Tamacebi-pour, N., & Jamshidi, A. H. (2005). Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: A double-blind, randomized pilot trial. Ethnopharmacology, 97, 281–284.

    Article  PubMed  Google Scholar 

  • Perry, E. K., Pikering, A. T., Wang, W. W., Houghton, P. J., & Perry, N. S. (1998). Medicinal plants and Alzheimer’s disease: integrating ethnobotanical and contemporary scientific evidence. Journal of Alternative and Complementary Medicine, 4, 419–428.

    Google Scholar 

  • Perry, E. K., Pikering, A. T., Wang, W. W., Houghton, P. J., & Perry, N. S. (1999). Medicinal plants and Alzheimer’s disease: from etnobotany to phytotherapy. Journal of Pharmacology, 51, 527–534.

    Article  Google Scholar 

  • Pittler, M. H., & Ernst, E. (2000). Efficacy of kava extract for treating anxiety: Systematic review and meta-analysis. Journal of Clinical Psychopharmacology, 20, 84–89.

    Article  PubMed  Google Scholar 

  • Richelson, E. (1994). Pharmacology of antidepressants-characteristic of the ideal drug. Mayo Clinic Proceeding, 69, 1069–1081.

    Google Scholar 

  • Rios, J. L., Recio, M. C., Giner, R. M., & Manez, S. (1996). An update review of saffron and its active constituents. Phytotherapy Research, 10, 189–193.

    Article  Google Scholar 

  • Schelosky, L., Raffauf, C., & Jendroska, K. (1995). Kava and dopamine antagonism [letter]. Journal of Neurology, Neurosurgery and Psychiatry, 58, 639–640.

    Google Scholar 

  • Schulz, V. (2003). Gingko extract or cholinesterase inhibitors in patients with dementia: what clinical trials and guidelines fail to consider. Phytomedicine, 14(Suppl. 10), 74–79.

    Article  Google Scholar 

  • Schulz, V., Hansel R., & Tyler, V. E. (1998). Rational phytotherapy: a physicians’ guide to herbal medicine (3rd ed.). Berlin, Germany: Springer-Verlag.

    Google Scholar 

  • Sensenig, J., Marrongelle, J., Johnson, M., & Staverosky, T. (2001). Treatment of migraine with targated nutrition focused on improved assimilation and eliminiation. Alternative Medicine Review, 6, 488–494.

    PubMed  Google Scholar 

  • Sproule, B.A., Busto, U.E., & Buckle, C. (1999). The use of non-prescription sleep products in the elderly. International Journal of Geriatric Psychiatry 14, 851–857.

    Article  PubMed  Google Scholar 

  • Szatmari, S. Z., & Whitehouse, P. J. (2003). Vinpocetine for cognitive impairment and dementia (Cochrane Review). Cochrane Database Systematic Review CD003119.

    Google Scholar 

  • Wake, G., Court, J., Pikering, A., Lewis, R., Wilkins, R., & Perry, E. (2000). CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory. Journal of Ethnopharmacology, 69, 105–114.

    Article  PubMed  Google Scholar 

  • Wheatley, D. (1999). Hypericum in seasonal affective disorder (SAD). Current Medical Research Opinion, 15, 33–7.

    Article  Google Scholar 

  • Xu, S. S., Gao, Z. X., & Weng, Z. (1995). Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer’s disease. Zhongguo Yao Li Xue Bao, 16, 391–395.

    PubMed  Google Scholar 

  • Zhang, R. W., Tang, X. C., & Han, Y. Y. (1991). Drug evaluation of huperzine A in the treatment of senile memory disorders [in Chinese; English abstract]. Zhongguo Yao Li Xue Bao, 12, 250–252.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. FB Pharmacols, Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, South Kargar Street, Tehran 13337, Iran

    Shahin Akhondzadeh

Authors
  1. Shahin Akhondzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Professor Emeritus of Psychology, Georgia State University, Atlanta, Georgia

    Luciano L’Abate

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer

About this chapter

Cite this chapter

Akhondzadeh, S. (2007). Herbal Medicines in the Treatment of Psychiatric and Neurological Disorders. In: L’Abate, L. (eds) Low-Cost Approaches to Promote Physical and Mental Health. Springer, New York, NY. https://doi.org/10.1007/0-387-36899-X_6

Download citation

Publish with us

Policies and ethics

Search

Navigation